Instadose Pharma Corp. (OTC MKTS: INSD) Expands Global Footprint Through ‘Global Distribution Platform’ Strategy; Stock Jumps 24.07%

Instadose Pharma Corp. (OTC MKTS: INSD) Is increasingly becoming a force in worldwide medicinal cannabis. From multiple growing and cultivation sites it is distributing to pharmaceutical firms globally. And it is negotiating for more.

The market likes its fast growth. Last evening it closed at $33.50, jumping 24.07% in heavy trading volume of 17,207. That’s more than a five-fold increase from its daily average of 3,057. 

INSD stock is on a tear. In September it was $5 a share. Before its reverse merger on September 24, it was a shell company with no operations.

INSD’s Global Distribution Platform is gaining momentum in a large market. The global medicinal cannabis market is anticipated to reach $46.18 billion by 2026 at a CAGR of 22.9% from 2021, according to research by Market Data Forecast.

It also distributes cannabinoid oil worldwide.

INSD keeps expanding its global footprint. It already touches EU in Europe via Portugal. Through multiple entryways it now touches five continents: Asia, North America, South America, Africa and now Europe.

It is also a good partner with emerging nations. It focuses on INSD projects that help impoverished countries use clean water.

INSD is also focused on sustainable and long-term agreements. The goal is to give back to nationals and the environment. Instadose aims to increase

fresh water, jobs, education, food, quality of life and security.

Instadose Pharma Corp. (OTC MKTS: INSD) is seeking to create a large, outdoor growing, cultivation and global distribution program for its Medicinal Cannabis and Cannabinoid Oil. It would, through its Global Distribution Platform,  gain global access to a new wholesale market worldwide. 

This wholesale marketplace would then offer low-cost product as a bulk and active pharmaceutical ingredient. It would be large, sustainable, consistent, diverse and high quality.  

INSD Chairman Grant Sanders said, “The commoditization of Cannabis will have a huge impact on countries where it can be grown outdoors, particularly in the developing world. The hope is that these countries will benefit from the development of a global market for Medicinal Cannabis.

It is also focused on its three growing and cultivation centers in: Democratic Republic of the Congo (DRC), South Africa and Mexico.

INDS has total 40,000 hectares of outdoor going space in three locations. This accounts for more growing space than all three of its largest competitors combined.

It sells its medicinal cannabis to a growing number of countries and markets  through established entry points. 

It established them in these locations:

  • The Democratic Republic of the Congo (DRC)
  •  Republic of India
  • Columbia, Mexico
  • Republic of North Macedonia
  • Portuguese Republic
  • Canada
  • Argentina

Grant Sanders, CEO of INSD, called the international relationships strategic. They bridge between growing/cultivation locations and selling markets. The Portuguese Republic, for instance, gives INSD access to the EU.

Raising its profile as a significant participant in the global environmental change, in January 2022 INSD will attend and be a speaker at  Future Cannabis Strategies Europe. The focus of that London conference will be the ‘Future Of Medicinal Cannabis’. 

INSD will emphasize the growing global role of medicinal cannabis and its impact on developing nations. It will discuss its benefits and potential impact on emerging nations.
Sanders added, “Food and water security, as well as, the environment and climate change, are global issues and Medicinal Cannabis could be central to the story as a green renewable resource.”